LIVINGCELL ApS: Financial statements 2023
CVR: 27205607
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 343,521 and a net result of DKK 267,779 compared with DKK 251,431 the year before. That is an increase of 5.3% compared with the year before. Equity in the 2023 report amounted to DKK 405,054. The solvency ratio was 45.6%.
- Gross Profit
- DKK 343,521
- Profit/Loss
- DKK 267,779
- Equity
- DKK 405,054
- Total Assets
- DKK 887,935
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 344 t. | 268 t. | 405 t. | - |
| 2022 | - | 326 t. | 251 t. | 387 t. | - |
| 2021 | - | 365 t. | 282 t. | 416 t. | - |
| 2020 | - | 298 t. | 228 t. | 362 t. | - |
| 2019 | - | 669 t. | 516 t. | 649 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout LIVINGCELL ApS
LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.